Morales-Garcia, J.; Susin, C.; Alonso-Gil, S.; Perez, D. I.; Palomo, V.; Perez, C.; Conde, S.; Santos, A.; Gil, C.; Martinez, A.; Perez-Castillo, A.
[2013]. Glycogen synthase kinase-3 inhibitors as potent therapeutic agents for the treatment of Parkinson disease. ACS Chem. Neurosci. 2013, 4, 350-360
Perez-Gonzalez, R.; Pascual, C.; Antequera, D.; Bolos, M.; Redondo, M.; Perez, D. I.; Pérez-Grijalba, V.; Krzyzanowska, A.; Sarasa, M.; Gil, C.; Ferrer, I.; Martinez, A.; Carro, E
[2013]. Phosphodiesterase 7 inhibitor reduced cognitive impairment and pathological hallmarks in a mouse model of Alzheimer's disease. Neurobiol. Aging 2013, 34, 2133-2145
Emerging drugs and targets for Parkinson’s disease. Ed. A. Martinez, C. Gil.
[2013]. Royal Society of Chemistry. 2013, ISBN 978-1-84973-617-6
Medina-Rodríguez, E. M.; Arenzana, F. J.; Pastor, J.; Redondo, M.; Palomo, V.; García de Sola, R.; Gil, C.; Martínez, A.; Bribián, A.; de Castro, F.
[2013]. Inhibition of endogenous Phosphodiesterase 7 promotes oligodendrocyte precursor differentiation and survival. Cell. Mol. Life Sci. 2013, 70, 3449-3462
González-García, C.; Bravo, B.; Ballester, A.; Gómez-Pérez, R.; Eguiluz, C.; Redondo, M.; Martínez, A.; Gil, C.; Ballester, S.
[2013]. Comparative assessment of phosphodiesterase 4 and 7 inhibitors as therapeutic agents in Experimental Autoimmune Encephalomyelitis. Br. J. Pharmacol., 2013, 170, 602-613
Martinez, A.; Perez, D. I.; Gil, C.
[2013]. Lessons learnt from glycogen synthase kinase 3 inhibitors development for Alzheimer’s disease. Curr. Top. Med. Chem. 2013, 13, 1808-1819
Redondo, M.; Soteras, I.; Brea, J.; Gonzalez-García, A.; Cadavid, M. I.; Loza, M. I.; Martinez, A.; Gil, C.; Campillo, N.
[2013]. Unraveling phosphodiesterase surfaces. Identification of phosphodiesterase 7 allosteric modulation cavities. Eur. J. Med. Chem. 2013, 70, 781-788
Pedro González-Naranjo, Concepción Pérez, Nuria E. Campillo and Juan A. Páez.
[2013]. Cannabinoids As Multitarget Drugs For Alzheimer Disease. Curr. Alzheimer Res. 2013, 0(3):229-39
Guerra, A.; Gonzalez-Naranjo, P.; Campillo, N. E.; Cerecetto, H.; Gonzalez, M.; Paez, J. A.
[2013]. Artificial neural networks based on CODES descriptors in pharmacology: identification of novel trypanocidal drugs against Chagas disease. Curr Comput Aided Drug Des, 2013 9, (1), 130-40
de Munck E, Munoz-Saez E, Miguel BG, Solas MT, Ojeda I, Martinez A, Gil C and Arahuetes RM
[2013]. beta-N-methylamino-l-alanine causes neurological and pathological phenotypes mimicking Amyotrophic Lateral Sclerosis (ALS): the first step towards an experimental model for sporadic ALS. Environ Toxicol Pharmacol 36(2): 243-255
Redondo, M.; Zarruk, J. G.; Ceballos, P.; Perez, D. I.; Perez, C.; Perez-Castillo, A.; Moro, M. A.; Brea, J.; Val, C.; Cadavid, M. I.; Loza, M. I.; Campillo, N. E.; Martinez, A. Gil, C.
[2012]. Neuroprotective efficacy of quinazoline type phosphodiesterase 7 inhibitors in cellular cultures and experimental stroke model Eur. J. Med. Chem. 2012, 47, 175-185
Palomo, V.; Perez, D. I.; Perez, C.; Morales-Garcia, J. A.; Soteras, I.; Alonso-Gil, S.; Encinas, A.; Castro, A.; Campillo, N. E.; Perez-Castillo, A.; Gil, C.; Martinez, A.
[2012]. 5-Imino-1,2,4-thiadiazoles: first small molecules as substrate competitive inhibitors of glycogen synthase kinase 3. J. Med. Chem. 2012, 55, 1645-1661
Gil, C.
[2012]. An introduction to solid-phase Palladium chemistry en Solid-phase Palladium chemistry, Vol 2. Ed. Peter J. H. Scott, Wiley-VCH. 2012, 3-21
Susín, C.; Morales-García, J. A.; Aguilar-Morante, D.; Palomo, V.; Sanz-SanCristobal, M.; Alonso-Gil, S.; Gil, C.; Santos, A.; Martinez, A.; Perez-Castillo, A.
[2012]. The new iminothiadiazole derivative VP1.14, ameliorates hippocampal damage after an excitotoxic injury. J. Neurochem. 2012, 122, 1193-1202
Redondo, M.; Palomo, V.; Brea, J.; Perez, D. I.; Martín-Alvarez, R.; Perez, C.; Paul-Fernández, N.; Conde, S.; Cadavid, M. I.; Loza, M. I.; Mengod, G.; Martinez, A.; Gil, C.; Campillo, N. E.
[2012]. Identification in silico and experimental validation of novel phosphodiesterase 7 inhibitors with efficacy in experimental autoimmune encephalomyelitis mice. ACS Chem. Neurosci. 2012, 3, 793-803
Redondo, M.; Brea, J.; Perez, D. I.; Soteras, I.; Val, C.; Perez, C.; Morales-García, J. A.; Alonso-Gil, S.; Paul-Fernández, N.; Martín-Alvarez, R.; Cadavid, M. I.; Loza, M. I.; Perez-Castillo, A.; Mengod, G.; Campillo, N. E.; Martinez, A.; Gil, C.
[2012]. Effect of phosphodiesterase 7 (PDE7) inhibitors in experimental autoimmune encephalomyelitis mice. Discovery of a new chemically diverse family of compounds. J. Med. Chem. 2012, 55, 3274-3284
Morales-Garcia, J.; Luna-Medina, R.; Alonso-Gil, S.; Sanz-SanCristobal, M.; Palomo, V.; Gil, C.; Santos, A.; Martinez, A.; Perez-Castillo, A.
[2012]. Glycogen synthase kinase 3β inhibition promotes adult hippocampal neurogenesis in vitro and in vivo. ACS Chem. Neurosci. 2012, 3, 963-971
